Din‐E Shan

1.3k total citations
44 papers, 885 citations indexed

About

Din‐E Shan is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Din‐E Shan has authored 44 papers receiving a total of 885 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Neurology, 15 papers in Cellular and Molecular Neuroscience and 11 papers in Molecular Biology. Recurrent topics in Din‐E Shan's work include Neurological disorders and treatments (19 papers), Parkinson's Disease Mechanisms and Treatments (13 papers) and Genetic Neurodegenerative Diseases (11 papers). Din‐E Shan is often cited by papers focused on Neurological disorders and treatments (19 papers), Parkinson's Disease Mechanisms and Treatments (13 papers) and Genetic Neurodegenerative Diseases (11 papers). Din‐E Shan collaborates with scholars based in Taiwan, United States and China. Din‐E Shan's co-authors include Ren‐Shyan Liu, Chang Chen, Michael Mu‐Huo Teng, Donald Ming-Tak Ho, Kwong‐Kum Liao, Bing‐Wen Soong, Chenming Sun, Ruey‐Meei Wu, Katrina Gwinn and Zin‐An Wu and has published in prestigious journals such as Annals of Neurology, Journal of Neurophysiology and Scientific Reports.

In The Last Decade

Din‐E Shan

44 papers receiving 850 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Din‐E Shan Taiwan 18 553 418 221 205 105 44 885
Nataša Dragašević Serbia 19 690 1.2× 478 1.1× 229 1.0× 145 0.7× 165 1.6× 47 1.2k
T. Shibazaki Japan 17 454 0.8× 379 0.9× 84 0.4× 88 0.4× 86 0.8× 43 924
Michel Van Zandijcke Belgium 13 424 0.8× 350 0.8× 203 0.9× 72 0.4× 92 0.9× 29 1.0k
Rollin J. Hawley United States 18 379 0.7× 432 1.0× 313 1.4× 52 0.3× 33 0.3× 30 945
N. Gouider‐Khouja Tunisia 16 496 0.9× 271 0.6× 236 1.1× 24 0.1× 167 1.6× 47 879
J Warter France 19 342 0.6× 500 1.2× 656 3.0× 41 0.2× 196 1.9× 55 1.2k
Frederick E. Lepore United States 20 534 1.0× 156 0.4× 102 0.5× 61 0.3× 184 1.8× 46 966
Francesca Magrinelli Italy 14 466 0.8× 201 0.5× 107 0.5× 41 0.2× 84 0.8× 51 784
Agnita J.W. Boon Netherlands 19 1.1k 1.9× 864 2.1× 134 0.6× 40 0.2× 143 1.4× 43 1.5k
Hiroya Utsumi Japan 18 619 1.1× 166 0.4× 120 0.5× 33 0.2× 24 0.2× 47 925

Countries citing papers authored by Din‐E Shan

Since Specialization
Citations

This map shows the geographic impact of Din‐E Shan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Din‐E Shan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Din‐E Shan more than expected).

Fields of papers citing papers by Din‐E Shan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Din‐E Shan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Din‐E Shan. The network helps show where Din‐E Shan may publish in the future.

Co-authorship network of co-authors of Din‐E Shan

This figure shows the co-authorship network connecting the top 25 collaborators of Din‐E Shan. A scholar is included among the top collaborators of Din‐E Shan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Din‐E Shan. Din‐E Shan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lv, Jianwei, Shumei Ma, & Din‐E Shan. (2024). Precision Nanotherapy for Spinal Cord Injury: Modulating SLC16A3 With Methylprednisolone-Loaded Nanoparticles. Neurospine. 22(2). 478–499. 1 indexed citations
2.
Wang, Vinchi, Tzu‐Chao Chuang, Ming‐Ching Kao, et al.. (2013). Polymorphic Ala-allele carriers at residue 1170 of HER2 associated with Parkinson's disease. Journal of the Neurological Sciences. 325(1-2). 115–119. 5 indexed citations
3.
Liu, Kang-Du, Din‐E Shan, Terry B. J. Kuo, & Cheryl C.H. Yang. (2013). The effects of bilateral stimulation of the subthalamic nucleus on heart rate variability in patients with Parkinson’s disease. Journal of Neurology. 260(7). 1714–1723. 26 indexed citations
4.
Shan, Din‐E, et al.. (2009). Absence of 4,977-bp deletion of blood cell mitochondrial DNA in patients with young-onset Parkinson's disease. Acta Neurologica Scandinavica. 91(2). 149–152. 2 indexed citations
5.
Wang, Vinchi, Tzu‐Chao Chuang, Bing‐Wen Soong, Din‐E Shan, & Ming‐Ching Kao. (2008). Octarepeat changes of prion protein in Parkinson's disease. Parkinsonism & Related Disorders. 15(1). 53–58. 16 indexed citations
6.
Wang, Vinchi, et al.. (2007). Polymorphism distribution of prion protein codon 117, 129 and 171 in Taiwan. European Journal of Epidemiology. 22(4). 257–261. 4 indexed citations
7.
Wu, Ruey‐Meei, et al.. (2006). The SCA17 phenotype can include features of MSA-C, PSP and cognitive impairment. Parkinsonism & Related Disorders. 13(4). 246–249. 52 indexed citations
8.
Lin, Yung‐Yang, et al.. (2004). Effect of Transcranial Magnetic Stimulation on Bimanual Movements. Journal of Neurophysiology. 93(1). 53–63. 27 indexed citations
9.
Shan, Din‐E, et al.. (2004). Presence of spinocerebellar ataxia type 2 gene mutation in a patient with apparently sporadic Parkinson's disease: Clinical implications. Movement Disorders. 19(11). 1357–1360. 27 indexed citations
10.
Lu, Ching‐Liang, Din‐E Shan, Chih‐Yen Chen, et al.. (2004). Impaired Gastric Myoelectrical Activity in Patients with Parkinson's Disease and Effect of Levodopa Treatment. Digestive Diseases and Sciences. 49(5). 744–749. 15 indexed citations
11.
Lin, Kon‐Ping, et al.. (2004). Guillain–Barré syndrome coexisting with pericarditis or nephrotic syndrome after influenza vaccination. Clinical Neurology and Neurosurgery. 106(2). 136–138. 18 indexed citations
12.
Wong, Ka Sing, Chin‐Song Lu, Din‐E Shan, et al.. (2003). Efficacy, safety, and tolerability of pramipexole in untreated and levodopa-treated patients with Parkinson's disease. Journal of the Neurological Sciences. 216(1). 81–87. 43 indexed citations
13.
Wu, Ruey‐Meei, Din‐E Shan, Chenming Sun, et al.. (2002). Clinical, 18F‐dopa PET, and genetic analysis of an ethnic Chinese kindred with early‐onset parkinsonism and parkin gene mutations. Movement Disorders. 17(4). 670–675. 26 indexed citations
14.
Wu, Ruey‐Meei, et al.. (2002). Genetic polymorphism of the CYP2E1 gene and susceptibility to Parkinson's disease in Taiwanese.. Journal of Neural Transmission. 109(11). 1403–1414. 10 indexed citations
15.
Yen, Der‐Jen, Din‐E Shan, & Shiang‐Ru Lu. (1998). Hyperthyroidism presenting as recurrent short paroxysmal kinesigenic dyskinesia. Movement Disorders. 13(2). 361–363. 25 indexed citations
16.
Liu, Yi‐Chung, Zin‐An Wu, Shuu‐Jiun Wang, Din‐E Shan, & Kon‐Ping Lin. (1998). Transient syndrome of continuous muscle fiber activity associated with staphylococcal infection. Movement Disorders. 13(3). 609–611. 3 indexed citations
17.
Shan, Din‐E, et al.. (1997). Genetic screening for Huntington's disease in Chinese patients with involuntary movements. Clinical Neurology and Neurosurgery. 99(4). 244–247. 1 indexed citations
18.
Lin, Kon‐Ping, et al.. (1996). Polyneuropathy associated with acute monoblastic leukemia: a case report.. Journal of the Chinese Medical Association. 58(6). 435–438. 1 indexed citations
19.
Shan, Din‐E, et al.. (1996). Belly dystonia induced by levodopa and biperiden in a case of suspected multiple‐system atrophy. Movement Disorders. 11(4). 455–457. 3 indexed citations
20.
Perez‐Polo, J. Regino, Perry J. Foreman, George R. Jackson, et al.. (1990). Nerve growth factor and neuronal cell death. Molecular Neurobiology. 4(1-2). 57–91. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026